retatrutide que es acaba de cambiar la conversación sobre obesidad. Pero hay letra chica. En el congreso de la Asociación Americana de Diabetes (ADA 2026) se presentó el primer estudio fase 3 de retatrutide Retatrutide: The End of Obesity

Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature

Our pilot experiments using the nonspecific serotonin receptor antagonist cyproheptadine reduced serotonin-induced effects on glucose

For tirzepatide, approximately three to four weeks

Instead, they are offering foods and drinks with more protein, fiber, and other nutrients in smaller portions

1 How retatrutide compares to Mounjaro and Wegovy Retatrutides side-effect rates are similar to other GLP-1 medications on the most common symptoms, with some differences at the higher doses